These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32649957)

  • 1. Read-across: Principle, case study and its potential regulatory application in China.
    Gao R; Guan N; Huang M; Foreman J; Kung M; Rong Z; Su Y; Sweet L; Zhu B; Zhu H; Zou H; Li B; Wang Y; Yin H; Yin Z; Zhang X
    Regul Toxicol Pharmacol; 2020 Oct; 116():104728. PubMed ID: 32649957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Workshop: use of "read-across" for chemical safety assessment under REACH.
    Patlewicz G; Roberts DW; Aptula A; Blackburn K; Hubesch B
    Regul Toxicol Pharmacol; 2013 Mar; 65(2):226-8. PubMed ID: 23266660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Read-across approaches: current applications and regulatory acceptance in Korea, Japan, and China.
    Lee BM; Lee SH; Yamada T; Park S; Wang Y; Kim KB; Kwon S
    J Toxicol Environ Health A; 2022 Mar; 85(5):184-197. PubMed ID: 34670481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Building scientific confidence in the development and evaluation of read-across.
    Patlewicz G; Ball N; Boogaard PJ; Becker RA; Hubesch B
    Regul Toxicol Pharmacol; 2015 Jun; 72(1):117-33. PubMed ID: 25857293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward Good Read-Across Practice (GRAP) guidance.
    Ball N; Cronin MT; Shen J; Blackburn K; Booth ED; Bouhifd M; Donley E; Egnash L; Hastings C; Juberg DR; Kleensang A; Kleinstreuer N; Kroese ED; Lee AC; Luechtefeld T; Maertens A; Marty S; Naciff JM; Palmer J; Pamies D; Penman M; Richarz AN; Russo DP; Stuard SB; Patlewicz G; van Ravenzwaay B; Wu S; Zhu H; Hartung T
    ALTEX; 2016; 33(2):149-66. PubMed ID: 26863606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A strategy for structuring and reporting a read-across prediction of toxicity.
    Schultz TW; Amcoff P; Berggren E; Gautier F; Klaric M; Knight DJ; Mahony C; Schwarz M; White A; Cronin MT
    Regul Toxicol Pharmacol; 2015 Aug; 72(3):586-601. PubMed ID: 26003513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relevance and Application of Read-Across - Mini Review of European Consensus Platform for Alternatives and Scandinavian Society for Cell Toxicology 2017 Workshop Session.
    Stuard SB; Heinonen T
    Basic Clin Pharmacol Toxicol; 2018 Sep; 123 Suppl 5():37-41. PubMed ID: 29524304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory acceptance of read-across.
    Chesnut M; Yamada T; Adams T; Knight D; Kleinstreuer N; Kass G; Luechtefeld T; Hartung T
    ALTEX; 2018; 35(3):413-419. PubMed ID: 30008009
    [No Abstract]   [Full Text] [Related]  

  • 9. Current trends in read-across applications for chemical risk assessments and chemical registrations in the Republic of Korea.
    Lee SH; Kim J; Kim J; Park J; Park S; Kim KB; Lee BM; Kwon S
    J Toxicol Environ Health B Crit Rev; 2022 Nov; 25(8):393-404. PubMed ID: 36250612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Workshop on the validation and regulatory acceptance of innovative 3R approaches in regulatory toxicology - Evolution versus revolution.
    Burgdorf T; Piersma AH; Landsiedel R; Clewell R; Kleinstreuer N; Oelgeschläger M; Desprez B; Kienhuis A; Bos P; de Vries R; de Wit L; Seidle T; Scheel J; Schönfelder G; van Benthem J; Vinggaard AM; Eskes C; Ezendam J
    Toxicol In Vitro; 2019 Sep; 59():1-11. PubMed ID: 30946968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The challenge of using read-across within the EU REACH regulatory framework; how much uncertainty is too much? Dipropylene glycol methyl ether acetate, an exemplary case study.
    Ball N; Bartels M; Budinsky R; Klapacz J; Hays S; Kirman C; Patlewicz G
    Regul Toxicol Pharmacol; 2014 Mar; 68(2):212-21. PubMed ID: 24378700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NAM-supported read-across: From case studies to regulatory guidance in safety assessment.
    Rovida C; Escher SE; Herzler M; Bennekou SH; Kamp H; Kroese DE; Maslankiewicz L; Moné MJ; Patlewicz G; Sipes N; Van Aerts L; White A; Yamada T; Van de Water B
    ALTEX; 2021; 38(1):140-150. PubMed ID: 33452529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives on trace chemical safety and chemophobia: risk communication and risk management.
    Lee BM; Kwon S; Cho YM; Kim KB; Seo K; Min CS; Kim K
    J Toxicol Environ Health A; 2019; 82(3):186-199. PubMed ID: 30741122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives on trace chemical safety and chemophobia: risk communication and risk management.
    Lee BM; Kwon S; Cho YM; Kim KB; Seo K; Min CS; Kim K
    J Toxicol Environ Health A; 2019; 82(2):113-127. PubMed ID: 30663519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Grouping of nanomaterials to read-across hazard endpoints: from data collection to assessment of the grouping hypothesis by application of chemoinformatic techniques.
    Lamon L; Asturiol D; Richarz A; Joossens E; Graepel R; Aschberger K; Worth A
    Part Fibre Toxicol; 2018 Sep; 15(1):37. PubMed ID: 30249272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The implementation of RAAF in the OECD QSAR Toolbox.
    Kuseva C; Schultz TW; Yordanova D; Tankova K; Kutsarova S; Pavlov T; Chapkanov A; Georgiev M; Gissi A; Sobanski T; Mekenyan OG
    Regul Toxicol Pharmacol; 2019 Jul; 105():51-61. PubMed ID: 30970268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards grouping concepts based on new approach methodologies in chemical hazard assessment: the read-across approach of the EU-ToxRisk project.
    Escher SE; Kamp H; Bennekou SH; Bitsch A; Fisher C; Graepel R; Hengstler JG; Herzler M; Knight D; Leist M; Norinder U; Ouédraogo G; Pastor M; Stuard S; White A; Zdrazil B; van de Water B; Kroese D
    Arch Toxicol; 2019 Dec; 93(12):3643-3667. PubMed ID: 31781791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporating lines of evidence from New Approach Methodologies (NAMs) to reduce uncertainties in a category based read-across: A case study for repeated dose toxicity.
    Pestana CB; Firman JW; Cronin MTD
    Regul Toxicol Pharmacol; 2021 Mar; 120():104855. PubMed ID: 33359265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harmonization of cancer and noncancer risk assessment: proceedings of a consensus-building workshop.
    Bogdanffy MS; Daston G; Faustman EM; Kimmel CA; Kimmel GL; Seed J; Vu V
    Toxicol Sci; 2001 May; 61(1):18-31. PubMed ID: 11294970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of category approaches, read-across and (Q)SAR: general considerations.
    Patlewicz G; Ball N; Booth ED; Hulzebos E; Zvinavashe E; Hennes C
    Regul Toxicol Pharmacol; 2013 Oct; 67(1):1-12. PubMed ID: 23764304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.